362 related articles for article (PubMed ID: 26347163)
21. [Treatment of locally advanced renal tumors].
Sánchez Zalabardo D; Millán Serrano JA; De Pablo Cárdenas A; Cuesta Alcalá JA
Actas Urol Esp; 2010 Feb; 34(2):134-41. PubMed ID: 20403277
[TBL] [Abstract][Full Text] [Related]
22. Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.
Shaw GL; Hussain M; Nair R; Bycroft J; Beltran L; Green JS; Powles T; Peters JL
Urol Int; 2012; 89(1):83-8. PubMed ID: 22614181
[TBL] [Abstract][Full Text] [Related]
23. The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy.
Rini BI; Campbell SC
J Urol; 2007 Jun; 177(6):1978-84. PubMed ID: 17509276
[TBL] [Abstract][Full Text] [Related]
24. Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives.
Berquist SW; Yim K; Ryan ST; Patel SH; Eldefrawy A; Cotta BH; Bradshaw AW; Meagher MF; Bindayi A; McKay RR; Autorino R; Staehler M; Derweesh IH
Int J Urol; 2019 May; 26(5):532-542. PubMed ID: 30943578
[TBL] [Abstract][Full Text] [Related]
25. [A case of adrenal metastasectomy in renal cell carcinoma after neoadjuvant therapy with sunitinib].
Hamada A; Sunada T; Kato K; Sawada A; Kawanishi H; Okumura K
Hinyokika Kiyo; 2014 Feb; 60(2):79-82. PubMed ID: 24755818
[TBL] [Abstract][Full Text] [Related]
26. Management of metastatic renal cell carcinoma progressed after sunitinib or another antiangiogenic treatment.
Iacovelli R; Palazzo A; Trenta P; Mezi S; Pellegrino D; Naso G; Cortesi E
Am J Clin Oncol; 2014 Dec; 37(6):611-5. PubMed ID: 23388560
[TBL] [Abstract][Full Text] [Related]
27. Sarcomatoid dedifferentiation in metastatic clear cell renal cell carcinoma and outcome on treatment with anti-vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective analysis.
Beuselinck B; Lerut E; Wolter P; Dumez H; Berkers J; Van Poppel H; Joniau S; Oyen R; De Wever L; Strijbos M; Paridaens R; Schöffski P
Clin Genitourin Cancer; 2014 Oct; 12(5):e205-14. PubMed ID: 24861951
[TBL] [Abstract][Full Text] [Related]
28. Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report.
Koie T; Ohyama C; Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y
BMC Res Notes; 2013 Nov; 6():484. PubMed ID: 24267160
[TBL] [Abstract][Full Text] [Related]
29. Axitinib in metastatic renal cell carcinoma: beyond the second-line setting.
Umeyama Y; Shibasaki Y; Akaza H
Future Oncol; 2017 Sep; 13(21):1839-1852. PubMed ID: 28707479
[TBL] [Abstract][Full Text] [Related]
30. Prolonged response to cytoreductive surgery and sunitinib in an elderly patient with synchronous multiple metastases from renal cell carcinoma.
Locatelli MC; Miedico A; D'Antona A; Longo G; Maggioni M; Maggioni A; Tombolini P; Tabiadon D
Tumori; 2010; 96(3):478-82. PubMed ID: 20845812
[TBL] [Abstract][Full Text] [Related]
31. Axitinib in the treatment of metastatic renal cell carcinoma.
Ho TH; Jonasch E
Future Oncol; 2011 Nov; 7(11):1247-53. PubMed ID: 22044199
[TBL] [Abstract][Full Text] [Related]
32. Surgery for metastases of renal cell carcinoma: outcome of treatments and preliminary assessment of Leuven-Udine prognostic groups in the targeted therapy era.
Tornberg SV; Visapää H; Kilpeläinen TP; Taari K; Järvinen R; Erkkilä K; Nisen H; Järvinen P
Scand J Urol; 2018; 52(5-6):419-426. PubMed ID: 30663485
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant therapy of renal cell carcinoma: a novel treatment option in the era of targeted therapy?
Schrader AJ; Steffens S; Schnoeller TJ; Schrader M; Kuczyk MA
Int J Urol; 2012 Oct; 19(10):903-7. PubMed ID: 22640774
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive nephrectomy in metastatic clear-cell renal cell carcinoma: perspectives in the tyrosine kinase inhibitor era.
Biswas S; Kelly J; Eisen T
Oncologist; 2009 Jan; 14(1):52-9. PubMed ID: 19147692
[TBL] [Abstract][Full Text] [Related]
35. Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches.
Patel N; Woo J; Liss MA; Palazzi KL; Randall JM; Mehrazin R; Jabaj R; Mirheydar HS; Gillis K; Lee HJ; Patterson AL; Kane CJ; Millard F; Derweesh IH
Can J Urol; 2016 Apr; 23(2):8227-33. PubMed ID: 27085828
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of T4 renal cell carcinoma after a neoadjuvant targeted therapy using sunitinib: report of a case.
Ueda K; Noguchi M; Suekane S; Moriya F; Nagayoshi R; Ejima K; Momozono K; Matsuoka K
Kurume Med J; 2011; 58(3):95-8. PubMed ID: 22531125
[TBL] [Abstract][Full Text] [Related]
37. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
Ljungberg B
Curr Urol Rep; 2013 Feb; 14(1):19-25. PubMed ID: 23212738
[TBL] [Abstract][Full Text] [Related]
38. Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.
Powles T; Sarwar N; Stockdale A; Sarker SJ; Boleti E; Protheroe A; Jones R; Chowdhury S; Peters J; Oades G; O'Brien T; Sullivan M; Aitchison M; Beltran L; Worth D; Smith K; Michel C; Trevisan G; Harvey-Jones E; Wimalasingham A; Sahdev A; Ackerman C; Crabb S
JAMA Oncol; 2016 Oct; 2(10):1303-1309. PubMed ID: 27254750
[TBL] [Abstract][Full Text] [Related]
39. Axitinib in metastatic renal cell carcinoma.
Albiges L; Gizzi M; Carton E; Escudier B
Expert Rev Anticancer Ther; 2015 May; 15(5):499-507. PubMed ID: 25907705
[TBL] [Abstract][Full Text] [Related]
40. Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA.
Pal SK; Signorovitch JE; Li N; Zichlin ML; Liu Z; Ghate SR; Perez JR; Vogelzang NJ
Int J Urol; 2017 Apr; 24(4):272-278. PubMed ID: 28253548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
